FLINT, Mich., April 17, 2019 /PRNewswire/ -- Diplomat
Pharmacy, Inc. (NYSE: DPLO), will release its
first-quarter 2019 operating results before market open
Tuesday, May 7. A conference call and
live webcast will be held at 8:30 a.m.
ET.
Shareholders and interested participants can listen to a live
broadcast by calling 833.286.5805 (647.689.4450 for international
callers) and entering participation code 7747209, starting about 15
minutes before the call. A live webcast of the conference call will
be available on the investor relations section of Diplomat's
website at ir.diplomat.is. The site will host an audio
recording and supplemental investor information for 90 days.
Diplomat executives Brian
Griffin, chairman and CEO, and Dan
Davison, chief financial officer, will also participate in
the Bank of America Merrill Lynch Healthcare Conference in
Las Vegas on May 14.
About Diplomat
Diplomat (NYSE: DPLO) is the nation's largest independent
provider of specialty pharmacy and infusion services. Diplomat
helps people with complex and chronic health conditions in all 50
states, partnering with payers, providers, hospitals,
manufacturers, and more. Rooted in this patient care expertise,
Diplomat also serves payers through CastiaRx, a leading specialty
benefit manager, and offers tailored solutions for healthcare
innovators through EnvoyHealth. Diplomat opened its doors in 1975
as a neighborhood pharmacy with one essential tenet: "Take good
care of patients and the rest falls into place." Today, that
tradition continues — always focused on improving patient care. For
more information, visit diplomat.is.
CONTACT:
Terri Anne
Powers, Vice President of Investor Relations
312.889.5244 | tpowers@diplomat.is
Kali Lucas, Partner Marketing
Supervisor
810.768.9580 | press@diplomat.is
View original content to download
multimedia:http://www.prnewswire.com/news-releases/diplomat-to-release-first-quarter-2019-operating-results-may-7-participate-in-bank-of-america-merrill-lynch-healthcare-conference-may-14-300834063.html
SOURCE Diplomat Pharmacy, Inc.